Cargando…

Nursing management of treatment-related venous thromboembolism in patients with multiple myeloma

OBJECTIVES: Venous thromboembolism (VTE) is a common complication among patients with newly diagnosed multiple myeloma (NDMM). Therefore, this study aimed to analyze the incidence and risk factors associated with VTE in the current era of thromboprophylaxis and to propose appropriate nursing measure...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Bianhong, Liu, Chao, Lin, Zeyu, Geng, Chuanying, Zhang, Zhiyao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151651/ https://www.ncbi.nlm.nih.gov/pubmed/37144028 http://dx.doi.org/10.3389/fmed.2023.1153694

Ejemplares similares

Venous thromboembolism in multiple myeloma is associated with increased mortality
por: Schoen, Martin W., et al.
Publicado: (2020)

The Prognostic Role of Prothrombin Time and Activated Partial Thromboplastin Time in Patients with Newly Diagnosed Multiple Myeloma
por: Geng, Chuanying, et al.
Publicado: (2021)

Impact of Time-Varying Treatment Exposures on the Risk of Venous Thromboembolism in Multiple Myeloma
por: Brown, Joshua D., et al.
Publicado: (2016)

Validation of Risk-Adapted Venous Thromboembolism Prediction in Multiple Myeloma Patients
por: Barrett, Aisling, et al.
Publicado: (2021)

Evaluation of the Khorana score for prediction of venous thromboembolism in patients with multiple myeloma
por: Sanfilippo, Kristen M., et al.
Publicado: (2022)

P977: THE VENOUS THROMBOEMBOLISM RISK ASSESMENT MODELS IN MULTIPLE MYELOMA
por: Alp Kirkizlar, Tugcan, et al.
Publicado: (2023)

CD20 expression: A risk stratification factor for newly diagnosed multiple myeloma with t(11;14)
por: Jian, Yuan, et al.
Publicado: (2022)

Characteristics and Risk Factors of Ultra-High-Risk Patients with Newly Diagnosed Multiple Myeloma
por: Geng, Chuanying, et al.
Publicado: (2023)

Echocardiography‐defined pulmonary hypertension is an adverse prognostic factor for newly diagnosed multiple myeloma patients
por: Jian, Yuan, et al.
Publicado: (2022)

Venous Thromboembolism in Patients With Brain Cancer: Focus on Prophylaxis and Management
por: Kabashneh, Sohaip, et al.
Publicado: (2020)

Editorial: Venous thromboembolism and pregnancy
por: Tardy, Bernard, et al.
Publicado: (2022)

Newly diagnosed multiple myeloma patients with CD56 expression benefit more from autologous stem cell transplantation
por: Geng, Chuanying, et al.
Publicado: (2022)

Association Between Anticoagulation Outcomes and Venous Thromboembolism History in Chronic Thromboembolic Pulmonary Hypertension
por: Zhu, Yong-Jian, et al.
Publicado: (2021)

Differential Presentations of Arterial Thromboembolic Events Between Venous Thromboembolism and Atrial Fibrillation Patients
por: Lin, Yu-Sheng, et al.
Publicado: (2021)

Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma Receiving Immunomodulatory Therapy
por: Cornell, Robert Frank, et al.
Publicado: (2019)

Quality Improvement at an Academic Cancer Center: Venous Thromboembolism Prophylaxis in Patients With Multiple Myeloma
por: Baz, Rachid, et al.
Publicado: (2020)

Venous Thromboembolism Risk Score and Pregnancy
por: Raia-Barjat, Tiphaine, et al.
Publicado: (2022)

Editorial: COVID-19 and Venous Thromboembolism
por: Yamashita, Yugo
Publicado: (2021)

Approaches and Challenges in the Management of Multiple Myeloma in the Very Old: Future Treatment Prospects
por: Kaweme, Natasha Mupeta, et al.
Publicado: (2021)

Venous thromboembolism in in-hospital cirrhotic patients: A systematic review
por: da Cruz Renó, Leonardo, et al.
Publicado: (2022)

Venous Thromboembolism in Cancer: An Update of Treatment and Prevention in the Era of Newer Anticoagulants
por: Qureshi, Waqas, et al.
Publicado: (2016)

Treatment with rivaroxaban and monitoring of coagulation profiles in two dogs with venous thromboembolism
por: UCHIDA, Mona, et al.
Publicado: (2020)

Patient Characteristics and Preferences Regarding Anticoagulant Treatment in Venous Thromboembolic Disease
por: Lanéelle, Damien, et al.
Publicado: (2021)

Bleeding risk in patients with multiple myeloma treated for venous thromboembolism: a MarketScan analysis
por: Adrianzen-Herrera, Diego, et al.
Publicado: (2022)

Frequency of Venous Thromboembolism in Patients with Liver Cirrhosis
por: Omer Sultan, Muhammad, et al.
Publicado: (2020)

Venous Thromboembolism: An Unusual Presentation of Pulmonary Tuberculosis
por: Purayil, Nishan K, et al.
Publicado: (2021)

Preeclampsia and Venous Thromboembolism: Pathophysiology and Potential Therapy
por: Raia-Barjat, Tiphaine, et al.
Publicado: (2022)

Incidence Rates of Myomectomy-Related Mortality and Venous Thromboembolism in South Korea: A Population-Based Study
por: Yuk, Jin-Sung, et al.
Publicado: (2022)

Statin treatment and risk of recurrent venous thromboembolism: a nationwide cohort study
por: Nguyen, Cu Dinh, et al.
Publicado: (2013)

Management of venous thromboembolism: an update
por: Piran, Siavash, et al.
Publicado: (2016)

Venous thromboembolism: current management
por: Stevens, Hannah, et al.
Publicado: (2019)

Cocaine: A Provoking Risk Factor in Venous Thromboembolism
por: Griffin, Daniel, et al.
Publicado: (2019)

Clinical epidemiology of venous thromboembolic disease: An institutional registry
por: AlSheef, Mohammed, et al.
Publicado: (2022)

Anticoagulant for treatment and prophylaxis of venous thromboembolism patients with renal dysfunction: A systematic review and network meta-analysis
por: Fan, Guohui, et al.
Publicado: (2022)

Retrospective analysis of 264 multiple myeloma patients
por: GENG, CHUANYING, et al.
Publicado: (2013)

Retrospective analysis of genetic abnormalities and survival in 131 patients with multiple myeloma
por: LIU, NIAN, et al.
Publicado: (2015)

The Impact of Multiple Risk Factors for Venous Thromboembolism and Its Implications for Management
por: George, Anil P., et al.
Publicado: (2019)

Arterial thromboembolism in multiple myeloma in the context of modern anti-myeloma therapy
por: Chakraborty, Rajshekhar, et al.
Publicado: (2021)

Hypercholesterolemia and COVID-19: Statins for Lowering the Risk of Venous Thromboembolism
por: Vuorio, Alpo, et al.
Publicado: (2021)

Preventing Postpartum Venous Thromboembolism in 2022: A Narrative Review
por: Blondon, Marc, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ch2oj1kt9vvhr3toi0allu6avp